# Corporate earnings review: Sanofi, Capgemini, Crédit Agricole

> Overview of the performance of Sanofi with Dupixent, Capgemini, Crédit Agricole and Imerys, as well as Intel's stock market decline.

**In brief**: Economy event (severity: info) nationwide, first detected on 30 October 2026 at 16:22. Reported by 1 source (1 article), last updated on 30 October 2026 at 16:22.

- Category: Economy
- Severity: Info
- Place: Nationwide
- First detected: 30 October 2026 at 16:22
- Updated: 30 October 2026 at 16:22
- Web page: https://acturadar.com/en/events/5328-corporate-earnings-review-sanofi-capgemini-credit-agricole

## Sources (1 articles)

- [Sanofi : les ventes du médicament Dupixent s'envolent - 30/10](https://www.bfmtv.com/economie/replay-emissions/bfm-bourse/video-sanofi-les-ventes-du-medicament-dupixent-s-envolent-30-10_VN-202610300649.html) — BFMTV / RMC, 30 October 2026 at 16:22

---

Cite as: Acturadar, “Corporate earnings review: Sanofi, Capgemini, Crédit Agricole”, https://acturadar.com/en/events/5328-corporate-earnings-review-sanofi-capgemini-credit-agricole
Methodology: https://acturadar.com/en/methodology